Vancouver, British Columbia–(Newsfile Corp. – December 15, 2020) – CVR Medical Corp. (TSXV: CVM) (OTC: CRRVF) (“CVR Medical” or the “Company” or “we“) a Canadian listed and
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.